Paper Details

  1. Home
  2. Paper Details

Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris.

Author: BurnsTammy L, HillemanDaniel E, LingHua, PackardKathleen A

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Ranolazine improved angina class and reduced hospitalizations in patients with refractory angina pectoris.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Ranolazine is a novel antianginal medication approved for the treatment of chronic angina. There are only limited data concerning the efficacy of ranolazine in reducing healthcare resource utilization in patients with refractory angina pectoris. OBJECTIVE: The primary objective of this ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s40256-013-0038-z

データ提供：米国国立医学図書館（NLM）

Ranolazine: A New Oasis in the Desert of Refractory Angina

The desert of refractory angina is a challenging landscape where conventional treatments often fail to provide relief. This research explores the potential of ranolazine, a novel antianginal medication, to provide a much-needed oasis of relief for patients struggling with this debilitating condition.

Finding Relief in the Desert

The study found that ranolazine significantly improved angina symptoms and reduced hospitalizations in patients with refractory angina. It's like discovering a hidden spring in the desert, offering a source of life-giving relief for those enduring the harsh conditions.

Hope for a More Comfortable Journey

This research offers hope for a more comfortable and manageable journey through the desert of refractory angina. Ranolazine presents a new option for patients, allowing them to find respite from the persistent pain and discomfort, making their journey through this challenging landscape less arduous.

Dr.Camel's Conclusion

This study provides evidence that ranolazine can offer significant relief for patients with refractory angina. It's like finding a hidden oasis in the desert, providing a haven of relief for those enduring the harsh conditions. By offering a new treatment option, we can help patients navigate the challenging landscape of refractory angina with greater comfort and hope.
Date :
  1. Date Completed 2014-07-10
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

23873327

DOI: Digital Object Identifier

10.1007/s40256-013-0038-z

Related Literature

Article Analysis
・Side Effects of ranolazine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.